Connect with us
Research has found that the fourth dose of Pfizer’s COVID-19 vaccine for people aged 60 and above was effective in countering the virus and preventing severe...
COVID shots still work, but researchers hunt new improvements | Fortune You need to enable JavaScript to view this site.
A third vaccine dose increased antibodies in kids 5 to 11 against the Omicron strain, Pfizer says | Fortune You need to enable JavaScript to view...
Pfizer-BioNTech is moving into the next stages of development for a version of its COVID-19 antiviral pill that will be safe for children younger than 12...
Researchers revealed this week that most side effects of the mRNA vaccines from Pfizer and Moderna were mild and started fading away just a day after...
The Centers for Disease Control and Prevention (CDC) has made some changes to its vaccine guidance after factoring in the risk of myocarditis among those jabbed...
“It’s a tight window: two days to get tested and another two to get the drug,” he says. “If you are sitting at home and think...
Pfizer has become one of the world’s most admired companies | Fortune You need to enable JavaScript to view this site.
Omicron sends new daily COVID cases soaring 254% | Fortune You need to enable JavaScript to view this site.
As COVID deaths top 800,000, Delta and Omicron variants drive new cases | Fortune You need to enable JavaScript to view this site.
Recent Comments